ADCIRCA 20 MG TABLET

Tadalafil
$67.3444per EA
High Outlier

Strength

20 mg/1

NDC

66302046760

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

5/22/2024

Active Ingredients

TADALAFIL

Approval Type

New Drug (NDA)

FDA Application

NDA022332

On Market Since

5/22/2009

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+0.7%

5Y

+0.7%

All

+138.6%